|
|||||
SandostatinActive Ingredient(s): OctreotideFirst Approved by the FDA: October 21, 1988 Pharmaceutical Company: NOVARTIS Sandostatin Article SummaryOctreotide (brand Name Sandostatin, Novartis Pharmaceuticals) Is An Octapeptide That Mimics Natural Somatostatin Pharmacologically, Though It Is A More Potent Inhibitor Of Growth Hormone, Glucagon, And Insulin Than The Natural Hormone. It Was First Synthesized In 1979 By The Chemist Wilfried Bauer. contents 1 Pharmaceutical Effects 2 Adverse Effects 3 Uses 4 References 5 External Links // [edit] Pharmaceutical Effects since Octreotide Resembles Somatostatin In Physiological Activiti ... Read the Full Sandostatin ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Sandostatin Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to SandostatinInjection 0.05mg/ml, 0.1mg/ml, 0.2mg/ml, 0.5mg/ml, 1000mcg/ml, 100mcg/ml, 10mg, 1mg/ml, 200mcg/ml, 20mg, 30mg, 500mcg/ml, 50mcg/ml Related Drug Page(s): Related Search Results for SandostatinWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Sandostatin Text Link HTML Code: Related: Sandostatin industry storage drugs medication, rx answers Sandostatin, technical pharma class class Sandostatin, Sandostatin locate, community picture find Sandostatin, withdrawal overdosage study pharma Sandostatin, what is facts Sandostatin, lookup guidelines tablet overdosage pharmaceutical Sandostatin, listing Sandostatin, types Sandostatin. Octreotide news rx approval forums, study label digest interactions Octreotide, pharmacy almanac approval list Octreotide, dosage material digest picture review Octreotide, Octreotide internet schedule consultation instructions rx, feedback FDA drug condition classification Octreotide. Return to Top  Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Sandostatin.asp Last Updated June 27 2005 |
|||||
Home Page
